Tenon Medical, Inc. (TNON)
TNON Chart as of 2025-03-11
Stock Information
| CEO: | – |
| CFO: | – |
| Employees: | 21 |
| Address: | 104 Cooper Court, Los Gatos, CA, United States |
| Country: | United States |
| Website: | https://www.tenonmed.com |
| Listing Date: | – |
| Founded: | – |
| Founder: | – |
| Current Price: | 1.88 USD |
| Today Change: | 50.40% |
| Outstanding Shares: | 3,136,590 |
| Volume: | 235,513 |
| Avg Volume: | 111,846 |
| Expert Target Price: | 8.0000 (Institutions: 0) |
| EPS: | – |
| PER: | 0.0044793235 |
| Dividend Date: | – |
| Last Split Date: | 2024-09-06 |
| Last Split Factor: | 1:8 |
Key Executives
| Name | Title | Pay | Year |
|---|---|---|---|
| Mr. Richard M. Ferrari | Founder & Executive Chairman | — | — |
| Mr. Steven M. Foster | CEO, President & Director | 487.6k | — |
| Mr. Richard Ginn | Founder, CTO & Director | 350.23k | — |
| Mr. Kevin Williamson | Chief Financial Officer | — | — |
| Mr. Steve Moscaret | Sr. Vice President of Sales & Marketing | — | — |
Financials
Income Statement
| Metric | Amount |
|---|---|
| Total Revenue | nan |
| Cost Of Revenue | nan |
| Gross Profit | nan |
| Operating Income | nan |
| Net Income | nan |
Balance Sheet
| Metric | Amount |
|---|---|
| Total Assets | nan |
| Total Liabilities | – |
| Total Stockholder Equity | – |
Cash Flow
| Metric | Amount |
|---|---|
| Total Cash From Operating Activities | – |
| Capital Expenditures | – |
SEC Filings (Gemini Summaries)
| AccNo | Date | Summary |
|---|---|---|
| 0001213900-24-098375 | 2024-11-14 | Tenon Medical, Inc. files a 10-Q for the quarter ended Sept 30, 2024. TNON is listed on Nasdaq. Report contains unaudited financials and forward-looking statements. As of Nov 14, 2024, 3,136,589 common shares outstanding. |
| 0001213900-24-096236 | 2024-11-12 | Tenon Medical is registering for resale up to 2,445,700 common shares. These shares are issuable upon exercise of warrants purchased by a selling stockholder. Tenon will not receive proceeds from the resale but will from warrant exercises. The selling stockholder may sell shares at market or negotiated prices. |
| 9999999995-24-003426 | 2024-11-08 | Tenon Medical, Inc.’s S-1 (File #333-282704, CIK 0001560293) is effective as of Nov 8, 2024 at 4:30 PM. |
| 0001213900-24-095242 | 2024-11-07 | Tenon Medical requests SEC acceleration of its S-1 registration (File No. 333-282704) to be effective Nov 8, 2024, at 4:30 PM ET. Acknowledges SEC’s effectiveness declaration doesn’t relieve company responsibility. Asks for confirmation to counsel Jeff Wofford. |
| 0001213900-24-094236 | 2024-11-04 | Tenon Medical responds to SEC comments on its S-1 filing. Clarifications include understanding underwriter roles, warrant agreement filings, signed consents, and justification for secondary offering classification per Rule 415(a)(1)(i). Amendment No. 1 filed. |
News Summary
– Tenon Medical (TNON) to Release Earnings on Monday
2025-03-03 08:16:50 | ETF Daily News
Tenon Medical (NASDAQ:TNON – Get Free Report) is expected to be announcing its earnings results before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of ($3.77) per share and revenue of $0.90 million for the quarter.
Link
Analysis of Today’s Move
Tenon Medical (TNON) experienced a rally today, likely fueled by a combination of factors. Anticipation surrounding the upcoming earnings release on March 10th is a primary driver. Investors often speculate on potential surprises or positive outlooks. The expected revenue of $0.90 million could be interpreted optimistically by some traders.
The news of the upcoming earnings release can often trigger speculative buying. Some investors may be positioning themselves ahead of the report. This anticipation can create short-term positive price movement. However, the expected loss per share of ($3.77) tempers excessive enthusiasm.
SEC filings reveal activity concerning share registration and potential dilution. The filing of S-1 registration statement going effective on November 8th implies that they needed the capital raise. This activity might usually create selling pressure. However, the current rally suggests the market is overlooking these potential risks.
The resale registration of common shares, as detailed in the November 12th filing, is also relevant. The shares are linked to warrants, which could dilute the stock. The rally may also suggest investors believe in Tenon’s longer term plan and prospects.
Ultimately, the reasons behind the rally are complex. The earnings release and the stock registration are key points. The limited information available restricts a precise explanation. Further analysis after the earnings release will provide more insights.
This stock has shown a change of 50.40% today.
Please consider that all investment decisions carry risk;
none of the content here should be construed as financial advice.
Always do your own research or consult a professional before making investment decisions.
The information provided in this article is for informational purposes only
and does not constitute legal, tax, or investment advice.
Investing involves risk, including the potential loss of principal.
Leave a Reply